• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Dr. Diana Bianchi named director of the National Institute of Child Health and Human Development

Dr. Diana Bianchi named director of the National Institute of Child Health and Human Development

August 26, 2016
CenterWatch Staff

NIH Director Francis S. Collins, M.D., Ph.D., has announced the selection of Diana W. Bianchi, M.D., as director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Dr. Bianchi is expected to join NIH on Oct. 31, 2016.

“Diana’s accomplishments as a prenatal geneticist, along with her leadership, clinical and research experience in both pediatrics and obstetrics, make her ideally suited to lead NICHD,” said Dr. Collins. “We are excited to have her join our team and lead this important area of research.”

As NICHD director, Dr. Bianchi will oversee research on pediatric health and development, maternal health, reproductive health, and intellectual and developmental disabilities. With an annual budget of approximately $1.3 billion, NICHD supports research grants and contracts at universities and other institutions across the country and overseas and an intramural research program of scientists working at NIH. The mission of NICHD is to enhance lives throughout all stages of human development, from preconception through adulthood, and to improve the health of children, adults, families and communities.

She will join NIH from the Floating Hospital for Children and Tufts Medical Center in Boston where she serves as the founding executive director of the Mother Infant Research Institute and vice chair for pediatric research. She is also the Natalie V. Zucker Professor of Pediatrics, and Obstetrics and Gynecology at Tufts University School of Medicine and the editor-in-chief of the international journal Prenatal Diagnosis.

A practicing medical geneticist with special expertise in reproductive genetics, Dr. Bianchi’s research focuses on prenatal genomics with the goal of advancing noninvasive prenatal DNA screening and diagnosis to develop new therapies for genetic disorders that can be administered prenatally.

Dr. Bianchi earned her M.D. from Stanford University School of Medicine, Stanford, California. Following medical school, she completed her residency training in pediatrics at Boston Children’s Hospital and her postdoctoral fellowship training in medical genetics and neonatal-perinatal medicine at Harvard Medical School. She is board-certified in all three specialties.

From 2011-2015 she served on NICHD’s National Advisory Council and is a past president of the International Society for Prenatal Diagnosis and the Perinatal Research Society. Dr. Bianchi is a former member of the Board of Directors of the American Society for Human Genetics and a former council member on both the Society for Pediatric Research and the American Pediatric Society. She was elected to membership in the Institute of Medicine (now National Academy of Medicine) in 2013.

Dr. Bianchi recently received two major lifetime achievement awards: the Landmark Award in 2015 from the American Academy of Pediatrics in recognition of her research and contributions to genetics and newborn care, and the Maureen Andrew Award for Mentoring in 2016 by the Society for Pediatric Research, which recognized her commitment to mentoring the next generation of clinician-scientists.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing